De Gruyter Open, Translational Neuroscience, 3(3), 2012
DOI: 10.2478/s13380-012-0031-z
Full text: Download
AbstractThere is an urgent necessity of designing translational strategies to schizophrenia, a mental disorder that affects 30 million people worldwide. Proteomic studies have been providing data enough to pave the way for that, but these need to be connected in a concise manner in order to translate laboratorial findings to real improvements in the lives of the patients.